These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 13114346)

  • 1. Physiological economy of darstine, 5-methyl-4-phenyl-1-(piperidyl)-3-hexanol methobromide, visceral anticholinergic agent.
    BEYER KH; TILLSON EK; RUSSO HF; PAULSON SF
    Am J Physiol; 1953 Oct; 175(1):39-44. PubMed ID: 13114346
    [No Abstract]   [Full Text] [Related]  

  • 2. The estimation of darstine, 1-(3-hydroxy-5-methyl-4-phenylhexyl)-1-methylpiper idinium bromide and its tertiary analog, 5-methyl-4-phenyl-1-(1-piperidyl)-3-hexanol hydrochloride, in plasma and urine.
    TILLSON EK; PAULSON SF; BEYER KH
    J Lab Clin Med; 1954 Dec; 44(6):880-4. PubMed ID: 13212254
    [No Abstract]   [Full Text] [Related]  

  • 3. Mepiperphenidol (darstine), 1-(3-hydroxy-5-methyl-4-phenylhexyl)-1-methylpiperidinium bromide; a visceral anticholinergic agent.
    MCMANUS EC; BOCHEY JM; BEYER KH
    J Pharmacol Exp Ther; 1953 Jul; 108(3):364-75. PubMed ID: 13070157
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacologic properties of antrenyl (oxyphenonium) (BA5473) diethyl(2-hydroxyethyl)methylammonium bromide alpha-phenyl-cyclohexaneglycolate, an anticholinergic agent.
    PLUMMER AJ; BARRETT WE; RUTLEDGE R; YONKMAN FF
    J Pharmacol Exp Ther; 1953 Jul; 108(3):292-304. PubMed ID: 13070148
    [No Abstract]   [Full Text] [Related]  

  • 5. Evaluation of newer anticholinergics in gastroenterology: secretory, motility, and clinical studies on darstine, pamine, and reltine.
    MCHARDY G; BECHTOLD JE; BROWNE DC
    J La State Med Soc; 1953 May; 105(5):174-81. PubMed ID: 13053051
    [No Abstract]   [Full Text] [Related]  

  • 6. [The use of a new synthetic anticholinergic agent with atropine-like action, N-methyl-N-(beta-dicyclohexyla-minoethyl)-piperidine in the therapy of dyskinesia of the biliarv tract].
    BARBI G
    Gazz Med Ital; 1963 Mar; 122():87-9. PubMed ID: 13966540
    [No Abstract]   [Full Text] [Related]  

  • 7. Some pharmacological properties of tricyclamol, a new anticholinergic agent.
    ZUPKO AG; PROKOP LD
    J Am Pharm Assoc Am Pharm Assoc; 1955 Mar; 44(3):160-3. PubMed ID: 14353744
    [No Abstract]   [Full Text] [Related]  

  • 8. [Research on changes in gastric secretion induced by a new synthetic anticholinergic agent].
    SPIGLIATI P; MASSIMO C
    Minerva Med; 1953 May; 44(40):1330-3. PubMed ID: 13072052
    [No Abstract]   [Full Text] [Related]  

  • 9. Cholinergic and anticholinergic drugs.
    BACHRACH WH; BRODY M
    Postgrad Med; 1958 Sep; 24(3):231-4. PubMed ID: 13591083
    [No Abstract]   [Full Text] [Related]  

  • 10. SUPPRESSION OF MILIARIA RUBRA (PRICKLY HEAT) BY A TOPICAL ANTICHOLINERGIC AGENT.
    STOUGHTON RB
    J Invest Dermatol; 1964 Apr; 42():287. PubMed ID: 14139556
    [No Abstract]   [Full Text] [Related]  

  • 11. Topical therapy with an anticholinergic agent in dermatologic conditions.
    SAUNDERS W; BABCOCK G
    N Y State J Med; 1956 Jan; 56(1):86-9. PubMed ID: 13280074
    [No Abstract]   [Full Text] [Related]  

  • 12. Depression of gastric secretion by a new anticholinergic agent.
    KLOTZ AP
    Am J Dig Dis; 1956 Mar; 1(3):108-15. PubMed ID: 13302185
    [No Abstract]   [Full Text] [Related]  

  • 13. Toxicologic investigation of oxyphencyclimine hydrochloride, a new anticholinergic agent.
    DELAHUNT CS; KAISER JA; BAJEK EM; McMURRAY SL
    Toxicol Appl Pharmacol; 1959 Jul; 1(4):391-405. PubMed ID: 13669022
    [No Abstract]   [Full Text] [Related]  

  • 14. A clinical evaluation of an anticholinergic agent in a sustained-release dose form.
    HOCK CW
    Curr Ther Res Clin Exp; 1962 Jul; 4():363-9. PubMed ID: 13907921
    [No Abstract]   [Full Text] [Related]  

  • 15. The newer anticholinergic agents.
    MACDONALD AD
    Practitioner; 1955 Sep; 175(1047):328-32. PubMed ID: 13254590
    [No Abstract]   [Full Text] [Related]  

  • 16. Experimental induction of conflict-behaviour in cats: the effect of some anticholinergic compounds.
    JACOBSEN E; SKAARUP Y
    Acta Pharmacol Toxicol (Copenh); 1955; 11(2):125-34. PubMed ID: 13258255
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacological background of modern anticholinergic drugs.
    HWANG K
    Am J Gastroenterol; 1956 Jul; 26(1):56-63. PubMed ID: 13339761
    [No Abstract]   [Full Text] [Related]  

  • 18. The anticholinergic actions of tridihexethyl iodide.
    OSTERBERG AC; GRAY WD
    Arch Int Pharmacodyn Ther; 1962 Jun; 137():250-66. PubMed ID: 14482588
    [No Abstract]   [Full Text] [Related]  

  • 19. Anticholinergic therapy of gastrointestinal disorders.
    INGELFINGER FJ
    N Engl J Med; 1963 Jun; 268():1454-7. PubMed ID: 13956494
    [No Abstract]   [Full Text] [Related]  

  • 20. Evaluation of newer anticholinergic agents.
    TEXTER EC; SMITH HW; BARBORKA CJ
    Gastroenterology; 1956 May; 30(5):772-8. PubMed ID: 13331059
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.